Sale!

MYBPC3 Gene Cardiomyopathy Dilated Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “MYBPC3 Gene Cardiomyopathy Dilated Genetic Test” is a specialized diagnostic assessment conducted at DNA Labs UAE, aimed at identifying mutations in the MYBPC3 gene, which have been associated with the development of dilated cardiomyopathy (DCM). Dilated cardiomyopathy is a condition characterized by the enlargement and weakening of the heart’s ventricles, leading to impaired cardiac function. The MYBPC3 gene plays a crucial role in the structure and function of the heart muscle, and mutations in this gene can disrupt heart muscle function, contributing to the development of DCM.

This genetic test is essential for individuals with a family history of dilated cardiomyopathy or those who exhibit symptoms of the condition, as it can provide definitive genetic evidence of the disease’s presence. Early detection through genetic testing allows for timely intervention and management strategies to delay the progression of the disease, improve quality of life, and reduce the risk of complications such as heart failure or arrhythmias.

The test is priced at 4400 AED and involves collecting a DNA sample, typically through a blood draw, which is then analyzed in the laboratory at DNA Labs UAE. The process is designed to be comprehensive and accurate, ensuring individuals receive critical information about their genetic predisposition to dilated cardiomyopathy. Upon completion of the test, genetic counselors at DNA Labs UAE can provide guidance and support to individuals and their families, helping them understand the results and implications for their health and lifestyle choices.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MYBPC3 Gene Cardiomyopathy Dilated Genetic Test

At DNA Labs UAE, we offer the MYBPC3 Gene Cardiomyopathy Dilated Genetic Test for individuals who suspect they may have this genetic disorder affecting the heart muscle. This test helps in the diagnosis and management of familial dilated cardiomyopathy (DCM).

Test Details

The MYBPC3 gene cardiomyopathy, also known as familial dilated cardiomyopathy (DCM), is a genetic disorder that affects the heart muscle. It is caused by mutations in the MYBPC3 gene, which provides instructions for making a protein called cardiac myosin-binding protein C. This protein plays a crucial role in regulating the contraction and relaxation of heart muscle cells. Mutations in the MYBPC3 gene disrupt the normal functioning of this protein, leading to the development of cardiomyopathy.

Our MYBPC3 Gene Cardiomyopathy Dilated Genetic Test utilizes NGS (Next-Generation Sequencing) technology, which allows us to analyze multiple genes simultaneously. This advanced sequencing technology enables us to identify specific mutations in the MYBPC3 gene, helping to diagnose individuals with this condition.

Test Components and Price

The MYBPC3 Gene Cardiomyopathy Dilated Genetic Test costs AED 4400.0. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.

Report Delivery and Test Department

Once the sample is received, the report will be delivered within 3 to 4 weeks. The test is conducted in our Genetics department, where our team of experts specializes in cardiovascular and pneumology disorders.

Pre-Test Information

Before undergoing the MYBPC3 Gene Cardiomyopathy Dilated Genetic Test, it is essential to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by MYBPC3 Gene Cardiomyopathy Dilated NGS Genetic DNA Test.

Role of Genetic Testing

NGS genetic testing for MYBPC3 gene cardiomyopathy can be used for various purposes:

  • Confirm a clinical diagnosis
  • Identify carriers of the gene mutation
  • Provide information for genetic counseling
  • Guide treatment decisions
  • Inform family members about their risk of developing the condition

It is important to note that genetic testing should always be done in consultation with a healthcare professional who specializes in genetics or cardiology. They can help interpret the results and provide appropriate recommendations for managing and treating MYBPC3 gene cardiomyopathy.

Don’t delay in getting tested. Contact DNA Labs UAE today to schedule your MYBPC3 Gene Cardiomyopathy Dilated Genetic Test.

Test Name MYBPC3 Gene Cardiomyopathy dilated Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MYBPC3 Gene Cardiomyopathy, dilated NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MYBPC3 Gene Cardiomyopathy, dilated NGS Genetic DNA Test gene MYBPC3
Test Details

MYBPC3 gene cardiomyopathy, also known as familial dilated cardiomyopathy (DCM), is a genetic disorder that affects the heart muscle. It is caused by mutations in the MYBPC3 gene, which provides instructions for making a protein called cardiac myosin-binding protein C.

Cardiac myosin-binding protein C plays a crucial role in regulating the contraction and relaxation of heart muscle cells. Mutations in the MYBPC3 gene disrupt the normal functioning of this protein, leading to the development of cardiomyopathy.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of MYBPC3 gene cardiomyopathy, NGS genetic testing can identify specific mutations in the MYBPC3 gene, helping to diagnose individuals with this condition.

NGS genetic testing for MYBPC3 gene cardiomyopathy can be used to confirm a clinical diagnosis, identify carriers of the gene mutation, and provide information for genetic counseling. It can also help guide treatment decisions and inform family members about their risk of developing the condition.

It is important to note that genetic testing should be done in consultation with a healthcare professional who specializes in genetics or cardiology. They can help interpret the results and provide appropriate recommendations for managing and treating MYBPC3 gene cardiomyopathy.